Two Sigma Advisers
ETTX

Two Sigma Advisers’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Two Sigma Advisers’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-168,700
Closed -$369K – 2987
2021
Q4 		$369K Sell
168,700
-60,300
-26% -$163K ﹤0.01% 2066
2021
Q3 		$765K Buy
229,000
+66,058
+41% +$179K ﹤0.01% 1739
2021
Q2 		$435K Buy
+162,942
New +$368K ﹤0.01% 1997

Other funds holding ETTX

TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return

Two Sigma Advisers's ETTX Position: Q1 2022 in Review

Two Sigma Advisers sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2022, closing a stake of 168,700 shares — an estimated $369K sold.

Two Sigma Advisers first reported a position in ETTX in Q2 2021 and held it in 3 quarters. The position peaked at $765K in Q3 2021. 22 funds tracked by Wall St. Rank hold ETTX as of Q1 2022.

  • Two Sigma Advisers reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2022 after selling out during the quarter.
  • Two Sigma Advisers sold 168,700 Entasis Therapeutics Holdings Inc. shares in Q1 2022, an estimated $369K.
  • Two Sigma Advisers first reported a position in Entasis Therapeutics Holdings Inc. in Q2 2021 and held it in 3 quarters.
  • Two Sigma Advisers's Entasis Therapeutics Holdings Inc. position peaked at $765K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2022.

Based on Two Sigma Advisers's 13F filing for Q1 2022, filed 16 May 2022.